Evidence map›Paper›PMID 36948621›Full record

ArticleInternal medicine (Tokyo, Japan)2023

A Rare Case of Blindness Caused by Syphilis with Malignant Hypertensive Nephropathy.

Minami Matsumoto, Shinya Yamamoto, Takuya Morinishi, Eishin Harima, Shintaro Nakayasu, Nobuki Iwamoto, Yuki Muraoka, Ayako Takahashi, Sachiko Minamiguchi, Motoko Yanagita

Open access · diamondAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Internal medicine (Tokyo, Japan), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.2field-weighted citation impact, top 51% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Minami MatsumotoDepartment of Nephrology, Kyoto University, Japan.
Shinya YamamotoDepartment of Nephrology, Kyoto University, Japan.
Takuya MorinishiDepartment of Nephrology, Kyoto University, Japan.
Eishin HarimaDepartment of Nephrology, Kyoto University, Japan.
Shintaro NakayasuDepartment of Neurosurgery, Kyoto University, Japan.
Nobuki IwamotoDepartment of Infection Control and Prevention, Kyoto University, Japan.
Yuki MuraokaDepartment of Ophthalmology and Visual Sciences, Kyoto University, Japan.
Ayako TakahashiDepartment of Ophthalmology and Visual Sciences, Kyoto University, Japan.
Sachiko MinamiguchiDepartment of Diagnostic Pathology, Kyoto University, Japan.
Motoko YanagitaDepartment of Nephrology, Kyoto University, Japan.
Kyoto University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The number of patients with syphilis has been rapidly increasing. Without treatment, syphilis can damage various organs and become life-threatening. We herein report a 29-year-old woman diagnosed with neurosyphilis, acute hydrocephalus, syphilitic uveitis combined with hypertensive retinopathy, and malignant hypertensive nephropathy. To our knowledge, this is the first report of syphilis complicated with malignant hypertensive nephropathy proven by a renal biopsy. Neurosyphilis was successfully treated with intravenous penicillin G, and severe hypertension subsequently resolved. However, delayed medical examinations and complications of syphilitic uveitis and hypertensive retinopathy resulted in irreversible visual loss. To prevent irreversible organ damage, early treatment is essential.

Indexed as

Hypertensive RetinopathyKidney DiseasesNeurosyphilisSyphilisUveitisAdultBlindnessFemaleHumansHypertension, RenalNephritishydrocephalushypertensive nephropathyhypertensive retinopathymalignant hypertensionneurosyphilissyphilis

Identifiers

PMID36948621
PMCPMC10686734
OpenAlexW4353004403

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.